• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The defensive role of human pulmonary alveolar macrophages and polymorphonuclear leukocytes against a strongly or weakly virulent strains of Cryptococcus neoformans].

作者信息

Tabeta H, Kohno N, Kamei K, Honda A, Unno H, Nagao K, Yamaguchi T, Miyaji M

机构信息

Division of Internal Medicine, Funabashi Municipal Medical Center, Japan.

出版信息

Nihon Kyobu Shikkan Gakkai Zasshi. 1991 Sep;29(9):1174-9.

PMID:1753544
Abstract

The phagocytic and killing activities of human pulmonary alveolar macrophages (PAM) and polymorphonuclear leukocytes (PMN), and superoxide (O2-) production in phagocytizing PAM and PMN were studied by using a strongly and weakly virulent strains of Cryptococcus neoformans (C. neoformans) in mice. The strongly virulent strain was encapsulated with a thick capsule while the other had a thin one. The phagocytic and killing activities of PAM and PMN against the strongly virulent strain were lower than against the weakly virulent one. There was no significant difference between PAM and PMN in terms of phagocytic or killing activities and O2- production. It seems likely that O2- plays no defensive role in the intracellular killing of C. neoformans by PAM and PMN because no correlation was found between the killing activity and O2- production. These results indicate that human PAM and PMN play an effective role in host defense against the weakly virulent strain of C. neoformans encapsulated with a thin capsule but are not effective against the strongly virulent strain encapsulated with a thick capsule.

摘要

相似文献

1
[The defensive role of human pulmonary alveolar macrophages and polymorphonuclear leukocytes against a strongly or weakly virulent strains of Cryptococcus neoformans].
Nihon Kyobu Shikkan Gakkai Zasshi. 1991 Sep;29(9):1174-9.
2
Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.荚膜在小鼠支气管肺泡巨噬细胞介导的新型隐球菌杀伤中的矛盾作用。
J Immunol. 1989 Jan 15;142(2):659-65.
3
Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.大肠杆菌荚膜对补体结合以及对人类吞噬细胞吞噬和杀伤作用的影响。
J Clin Invest. 1980 Jan;65(1):82-94. doi: 10.1172/JCI109663.
4
Immunology of infection caused by Cryptococcus neoformans.新型隐球菌引起的感染的免疫学
Methods Mol Med. 2005;118:193-8. doi: 10.1385/1-59259-943-5:193.
5
Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.干扰素-γ激活的巨噬细胞的杀菌活性。新生隐球菌的细胞外杀伤。
J Immunol. 1989 May 1;142(9):3219-24.
6
Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates.人类中性粒细胞对新型隐球菌的氧化杀伤作用。真菌甘露醇通过清除活性氧中间体起到保护作用的证据。
J Immunol. 1996 May 15;156(10):3836-40.
7
Natural cellular resistance of beige mice against Cryptococcus neoformans.米色小鼠对新型隐球菌的天然细胞抗性。
J Immunol. 1986 Dec 1;137(11):3624-31.
8
Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages.新型隐球菌的包囊化调节人肺泡巨噬细胞中的杀真菌活性和抗原呈递过程。
Clin Exp Immunol. 1994 Nov;98(2):217-23. doi: 10.1111/j.1365-2249.1994.tb06128.x.
9
Virulence, capsule size and lipid composition interrelation of Cryptococcus neoformans.
Microbiologica. 1984 Oct;7(4):371-4.
10
Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans.若你能,便来抓我:新型隐球菌的吞噬作用及逃避杀伤机制
FEMS Immunol Med Microbiol. 2012 Mar;64(2):147-61. doi: 10.1111/j.1574-695X.2011.00871.x.

引用本文的文献

1
Resistance of a Tn4351-generated polysaccharide mutant of Porphyromonas gingivalis to polymorphonuclear leukocyte killing.牙龈卟啉单胞菌Tn4351诱导的多糖突变体对多形核白细胞杀伤的抗性
Infect Immun. 1995 Feb;63(2):393-401. doi: 10.1128/iai.63.2.393-401.1995.